1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Melexis N.V.
  6. News
  7. Summary
    MELE   BE0165385973

MELEXIS N.V.

(MELE)
  Report
Real-time Euronext Bruxelles  -  03:26 2022-08-15 am EDT
82.60 EUR   +0.18%
07/27Melexis NV Announces Interim Dividend, Payable on October 18, 2022
CI
07/27TRANSCRIPT : Melexis NV, Q2 2022 Earnings Call, Jul 27, 2022
CI
07/27Melexis NV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Melexis N : Q4 and FY 2021 results – Full year sales of 643.8 million EUR

02/02/2022 | 12:59am EDT

Intermediate declaration by the Board of Directors
Ieper, Belgium - February 2nd, 2022, 07.00 hrs CET

Sales for the full year of 2021 were 643.8 million EUR, an increase of 27% compared to the previous year.
The EUR/USD exchange rate evolution had a negative impact on sales of 1% compared to 2020.
The gross result was 273.6 million EUR or 42.5% of sales, an increase of 38% compared to 2020. R&D expenses were 12.2% of sales, G&A was at 5.0% of sales and Selling was at 2.3% of sales.
The operating result was 148.4 million EUR or 23.1% of sales, an increase of 97% compared to 75.5 million EUR in 2020. The net result was 131.1 million EUR or 3.25 EUR per share, an increase of 89% compared to 69.3 million EUR or 1.72 EUR per share in 2020.

Sales for the fourth quarter of 2021 were 166.2 million EUR, an increase of 13% compared to the same quarter of the previous year and an increase of 2% compared to the previous quarter.
The EUR/USD exchange rate evolution had a positive impact on sales of 2% compared to the same quarter of last year and a positive impact of 1% compared to the previous quarter.
The gross result was 70.6 million EUR or 42.5% of sales, an increase of 21% compared to the same quarter of last year and flat compared to the previous quarter.
R&D expenses were 12.0% of sales, G&A was at 5.3% of sales and Selling was at 2.4% of sales.
The operating result was 37.8 million EUR or 22.8% of sales, an increase of 47% compared to the same quarter of last year and a decrease of 5% compared to the previous quarter.
The net result was 33.3 million EUR or 0.82 EUR per share, an increase of 39% compared to 24.0 million EUR or 0.59 EUR per share in the fourth quarter of 2020 and a decrease of 9% compared to the previous quarter.

Dividend

The Board of Directors approved on January 28th, 2022 to propose to the Annual Shareholders meeting to pay out over the result of 2021 a total dividend of 2.60 EUR gross per share. This amount contains an interim dividend of 1.30 EUR per share which was paid in October 2021 and a final dividend of 1.30 EUR per share which will be payable after approval of the Annual Shareholders meeting. The Melexis shares will start trading ex coupon on May 11, 2022 (opening of the market). The record date is May 12, 2022 (closing of the market) and the dividend will be payable as from May 13, 2022.

Outlook

Melexis expects sales in the first quarter of 2022 to be in the range of 177 to 183 million euro.
For the full year 2022, Melexis expects sales growth between 12% and 17%, with a gross profit margin around 42% and an operating margin around 23% at the midpoint of the sales guidance, all taking into account a EUR/USD exchange rate of 1.13.
For the full year 2022, Melexis expects CAPEX to be around 45 million EUR.

Business comment - Marc Biron, CEO:

"With a sales level of 166.2 million EUR in the fourth quarter and 643.8 million EUR for the full year, we have reached both a new record quarter and a new record year. These fantastic numbers, slightly above the upgraded guidance, led to a 97% increase of the operating result in 2021 compared with 2020. I would like to thank all Melexians for their great commitment and resilience in the face of the numerous supply chain headwinds.

In comparison to 2020, the outperforming product lines in 2021 were embedded lighting, temperature sensors, current sensors and latch and switches while in absolute terms, the highest increase is supported by the magnetic position sensor product line. In 2021, we launched no less than 16 new products. I am proud to announce that Melexis shipped on average 18 ICs per car produced worldwide, bringing our 2018 ambition of 20 ICs per car within reach. The current sensor and drivers product lines are expected to be the highest contributors to the revenue growth as they benefit the most from the general electrification trend.

Based on our customers' ordering behavior and the ongoing supply chain disruptions, we anticipate that the mismatch between supply and demand will not be resolved in 2022. We continue allocating the available materials across the customer base and working with our partners to further increase overall capacity.

Sales to automotive customers represented 90% of total sales in the fourth quarter of 2021 and 89% of total sales in the full year 2021. The portion of standard product (ASSPs) sales represented 73% of total sales in the fourth quarter and 72% in the full year 2021."

The statutory auditor PwC Bedrijfsrevisoren BV has confirmed that the audit, which is substantially complete, has not to date revealed any material misstatement in the draft consolidated accounts, and that the accounting data reported in the press release is consistent, in all material respects, with the draft consolidated accounts from which it has been derived.

Financial calendar
  • Publication Q1 Results 2022: April 27, 2022 (at 7 hrs CET)
  • Annual Shareholders Meeting: May 10, 2022
  • Dividend pay date: May 13, 2022 (ex coupon on May 11, 2022)
  • Publication Q2 Results 2022: July 27, 2022 (at 7 hrs CET)
  • Publication Q3 Results 2022: October 26, 2022 (at 7 hrs CET)
  • Publication FY 2022 Results: February 1, 2023 (at 7 hrs CET)

The company's results will be discussed in a conference call and an audiocast on Wednesday, February 2nd, 2022 at 10:30 hrs CET.

To register for the conference call (possibility to ask questions)

The conference call will be in English. You have to register for this conference call in advance. You can register by clicking here and filling out the requested information. After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call.

To register for the audiocast (no possibility to ask questions)

To register for the audiocast, click here.

For more information:
Investor Relations
Phone: +32 13 67 07 79
Email: investor@melexis.com

Download press release (PDF - 748 KB)

Disclaimer

Melexis NV published this content on 02 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 February 2022 05:58:02 UTC.


© Publicnow 2022
All news about MELEXIS N.V.
07/27Melexis NV Announces Interim Dividend, Payable on October 18, 2022
CI
07/27TRANSCRIPT : Melexis NV, Q2 2022 Earnings Call, Jul 27, 2022
CI
07/27Melexis NV Reports Earnings Results for the Second Quarter and Six Months Ended June 30..
CI
07/27Melexis Q2 2022 results – Second quarter sales of 208.4 million EUR
GL
07/27Melexis Q2 2022 results – Second quarter sales of 208.4 million EUR
AQ
07/27MELEXIS N.V. : Press Release
CO
07/27MELEXIS N.V. : Half-year results
CO
05/11MELEXIS N.V. : Ex-dividend day for final dividend
FA
05/10MELEXIS N.V. : Dividends
CO
05/10MELEXIS N.V. : Proxy Statments
CO
More news
Analyst Recommendations on MELEXIS N.V.
More recommendations
Financials
Sales 2022 832 M 853 M 853 M
Net income 2022 192 M 197 M 197 M
Net cash 2022 59,8 M 61,3 M 61,3 M
P/E ratio 2022 17,4x
Yield 2022 3,89%
Capitalization 3 331 M 3 415 M 3 415 M
EV / Sales 2022 3,93x
EV / Sales 2023 3,64x
Nbr of Employees 1 500
Free-Float 50,0%
Chart MELEXIS N.V.
Duration : Period :
Melexis N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MELEXIS N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 82,45 €
Average target price 84,88 €
Spread / Average Target 2,94%
EPS Revisions
Managers and Directors
Marc Biron Chief Executive Officer & Director
Karen van Griensven Chief Financial Officer
Françoise Chombar Chairman
Veerle Lozie Vice President-Operations & Information Technology
Damien Macq Chief Operating & Investment Officer
Sector and Competitors
1st jan.Capi. (M$)
MELEXIS N.V.-21.33%3 415
NVIDIA CORPORATION-36.39%468 476
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED-15.93%447 180
BROADCOM INC.-16.11%225 423
QUALCOMM, INC.-17.27%169 899
TEXAS INSTRUMENTS-1.64%169 383